The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients Wit
VESPA 2.0 - Virtual Environment for a Superior Neuropsychiatry Second Generation
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 3 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Vespa software
What it measured
Main measures
Montreal cognitive assessment (MoCA)
up to 6 weeks
Thinking and memory
Who could take part
MS (type not specified) · 50 to 70
Show the full criteria
Inclusion criteria
* Patients diagnosed with Alzheimer Disease, Multiple Sclerosis, Parkinson Disease * Severity of mild to moderate cognitive impairment * Sign informed consent
Exclusion criteria
* Important comorbidities with psychiatric syndromes * Failure to sign the informed consent * Atypical parkinsonisms * Clinical conditions that involve vision-related problems.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
VESPA 2.0 is based on an integrative and ecological approach used for the treatment of cognitive dysfunction in patients with MCI or other neurodegenerative disorders.
Loading reviews and guidelines…
History
Started
Mar 2021
Main results due
Dec 2022
Finished
Dec 2023